Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vintafolide + PLD vs PLD in Platinum-Resistant Ovarian Cancer
NCT00722592Phase 2Completed
- Sponsor
- Endocyte
- Start
- Sep 2008
- Primary completion
- Sep 2010
- Modality
- Prodrugs/Conditional Activator Small Molecules, Peptide-Drug Conjugates
01
Overview
A Phase 2 trial of vintafolide in ovarian cancer, sponsored by Endocyte. Started Sep 2008; status: completed.
02
Drugs
vintafolide
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT00722592.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00722592.